High PSA or an abnormal DRE may indicate prostate cancer. Diagnosis requires a biopsy:
Detection of prostate cancer
Existing diagnosis methods
Systematic Biopsy is invasive and has limited sensitivity.
MRI imaging followed by Targeted Biopsy, offers better sensitivity but adds significant waiting time and cost.
Ultrasound with PCaVision AI analysis, followed by targeted biopsy enables accurate diagnosis via a fast, cost-effective clinical pathway.
PCaVision diagnosis
Ultrasound imaging plus PCaVision (AI) analysis followed by Targeted Biopsy, delivers high quality diagnosis, and a minimum lapse time pathway at low cost.
By using PCaVision to detect and locate lesions, targeted biopsies can be performed without MRI in the diagnostic pathway, reducing both time and cost.